Rare diseases
Investigational molecules
Locations
Back to Spain60 clinical trials in Castilleja De La Cuesta, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)SpainOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
SpainStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
SpainStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
SpainA Phase 3 Randomized, Double-blind,Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Maridebart Cafraglutide in Adult Participants with Obstructive Sleep Apnea not on Positive Airway Pressure Therapy and Living with Overweight or Obesity (MARITIME-OSA-2)
SpainPhase 3 Extension Trial Evaluating Long‑Term Efficacy, Safety and Tolerability of maridebart cafraglutide in Adults with Obesity
SpainA study of the safety and efficacy of AC01 in patients with heart failure with reduced ejection fraction
SpainPhase 2 study of MK-7262 and enlicitide decanoate in adults with high lipoprotein(a)
SpainEfficacy and safety of oral semaglutide for weight loss in adults with overweight or obesity
SpainRandomized trial of elecoglipron with dapagliflozin versus placebo in adults with type 2 diabetes mellitus and impaired renal function
SpainPhase III randomized trial of elecoglipron to assess safety and weight loss in adults with obesity or overweight, with or without type 2 diabetes
SpainRO7795068 for Weight Loss in Adults With Obesity or Overweight Without Type 2 Diabetes
SpainThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on type 2 diabetes mellitus and obesity management, evaluating new therapeutic approaches for weight reduction and blood sugar control.
Multiple trials are investigating combination therapies with lifestyle modifications for optimal patient outcomes.
Comprehensive studies addressing atherosclerotic cardiovascular disease and hypercholesterolemia, testing new treatments for reducing major adverse cardiovascular events.
Research focuses on both primary prevention and management of established cardiovascular conditions.
Advanced research in multiple sclerosis treatment, including studies of new therapies and comparative analyses of existing treatments for relapsing-remitting forms.
Trials aim to improve treatment efficacy and patient quality of life.
Investigating treatments for chronic kidney disease, particularly in conjunction with diabetes and hypertension, evaluating novel therapeutic combinations.
Focus on slowing disease progression and improving outcomes in complex renal conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
